相关实验视频
概括
血酶治疗显著改善了五名患者的严重雷诺氏病. 这种血液净化技术重新打开了以前被阻塞的数字动脉,为耐火病例提供了新的希望.
科学领域:
- 血管医学 血管医学
- 免疫学 免疫学 免疫学
背景情况:
- 雷诺氏病的发病因子和治疗仍然不太清楚.
- 目前的治疗方案在严重病例中提供有限的成功.
研究的目的:
- 评估等离子体合成在治疗严重雷诺病不响应常规疗法的疗效.
主要方法:
- 五名患有严重雷诺氏病的患者接受了等离子体化.
- 超声波测速仪被用来评估治疗前后的数字动脉通透性.
主要成果:
- 血酶导致所有五名患者的临床状况明显改善.
- 超声波测速仪表明,以前被堵塞的数字动脉在血形成后成为专利,并保持如此.
结论:
- 血酶是一种有前途的治疗选择,用于严重的,耐火雷诺氏病.
- 这一程序似乎恢复了受影响的数字动脉的通透性.
相关概念视频
通过共同作者、期刊和引用图与本文相关的文章。
Measuring reaction-in-flight neutrons via the activation technique.
The Review of scientific instruments·2026
Successful use of vincristine in a quarter horse gelding with immune-mediated thrombocytopenia.
Journal of equine veterinary science·2026
Corrigendum to "Missed opportunities: The unknown impact of the COVID-19 pandemic on early childhood development in the WHO European region" [Pub. Health Practice 10 (2025) 100636].
Public health in practice (Oxford, England)·2026
Missed opportunities: The unknown impact of the COVID-19 pandemic on early childhood development in the WHO European region.
Public health in practice (Oxford, England)·2025
High-Frequency Basal Cell Carcinoma: Demographic, Clinical, and Histopathological Features in a Belgian Cohort.
Journal of clinical medicine·2025
Advancing the relevance of clinical trials for older patients.
Lancet (London, England)·2026
Mechanisms and Therapeutic Targeting of the cGAS-STING Pathway in Central Nervous System Disorders.
Current neuropharmacology·2026
Pharmacological Characterization of Digera muricata Ethanolic Extract in a Rodent Model of Hepatotoxicity.
Recent advances in inflammation & allergy drug discovery·2026
Medical Use of Cannabis and Derived Cannabis Products in a Sample of Young Adults in the United States.
Substance use & addiction journal·2026
Novel Mutations in the MC2R Gene in a Patient With Familial Glucocorticoid Deficiency (FGD): A Case Report and Functional Study.
Molecular genetics & genomic medicine·2026
Vladimiria souliei Ameliorated Aspirin-Induced Gastric Mucosal Injury by Activation Nrf2 and Inhibition RIP1 Signaling Pathways.
Biological & pharmaceutical bulletin·2026